digoxigenin - CISMeF

Preferred Label : digoxigenin;

MeSH definition : 3 beta,12 beta,14-Trihydroxy-5 beta-card-20(22)-enolide. A cardenolide which is the aglycon of digoxin. Can be obtained by hydrolysis of digoxin or from Digitalis orientalis L. and Digitalis lanata Ehrh.;

MeSH synonym : lanadigenin;

MeSH CAS label : Card-20(22)-enolide, 3,12,14-trihydroxy-, (3beta,5beta,12beta)-;

MeSH Related Number : 1672-46-4 (Digoxigenin);

Registry Number MeSH : 1672-46-4;

MeSH annotation : a Digitalis glycoside; do not confuse with DIGITOXIGENIN; /biosyn permitted if by plant;

Wikipedia link : https://en.wikipedia.org/wiki/Digoxigenin;

Codes EINECS : 216-806-2;

Is substance : O;

UNII : NQ1SX9LNAU;

InChIKey : SHIBSTMRCDJXLN-KCZCNTNESA-N;

Details

Origin ID

D004076;

UMLS CUI

C0012264;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- digoxigenin [OBI concept]
CISMeF manual mappings
- digoxigenin [Substance BNPC]
Record concept(s)
- digoxigenin [MeSH concept]
Related MeSH Supplementary Concept(s)
- 14-anhydrodigoxigenin [MeSH Supplementary Concept]
- 20,22-dihydrodigoxigenin [MeSH Supplementary Concept]
- 3 alpha-amino-3-desoxyoleandrigenin [MeSH Supplementary Concept]
- 3 beta-amino-3-desoxydigoxigenin [MeSH Supplementary Concept]
- 3 beta-amino-3-desoxygitoxigenin [MeSH Supplementary Concept]
- 3 beta-amino-3-desoxyuzarigenin [MeSH Supplementary Concept]
- 3-aminodigoxigenin [MeSH Supplementary Concept]
- 3-maleimidobenzoyl (digoxigenin-3-O-succinamido)aniline [MeSH Supplementary Concept]
- N-hydroxysuccinimidyl digoxigenin-3-O-methylcarbonyl-epsilon-aminocaproate [MeSH Supplementary Concept]
- dehydrodigoxigenin-digitoxosides [MeSH Supplementary Concept]
- digoxigenin-11-2',3'-dideoxyuridine 5'-triphosphate [MeSH Supplementary Concept]
- digoxigenin-11-deoxyuridine triphosphate [MeSH Supplementary Concept]
- digoxigenin-3-O-rutin [MeSH Supplementary Concept]
- digoxigenin-bis(digitoxoside) [MeSH Supplementary Concept]
- digoxigenin-conjugated NAD [MeSH Supplementary Concept]
- digoxigenin-mono(digitoxoside) [MeSH Supplementary Concept]
- syriogenin [MeSH Supplementary Concept]
Semantic type(s)
- Biologically Active Substance [UMLS semantic type]
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- digoxigenin [Substance BNPC]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients